Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,900 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Open Forum Infectious Diseases, 2023Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus
Schnittman S., Kolossváry M., Beck-Engeser G. et al.
Olink Target 96
Clinical and Experimental Dermatology, 2023HLA-C*15:02 and epidermal growth factor receptor inhibitor-induced erosive pustular dermatosis of the scalp
Zhang Y., Grice S., Wang N. et al.
Alimentary Pharmacology & Therapeutics, 2023Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease
Ungaro R., Hu L., Ji J. et al.
Nature Communications, 2023Interpreting biologically informed neural networks for enhanced proteomic biomarker discovery and pathway analysis
Hartman E., Scott A., Karlsson C. et al.
Journal of the American Heart Association, 2023Causal Effects of YKL‐40 on Ischemic Stroke and Its Subtypes: A 2‐Sample Mendelian Randomization Study
Xu Q., Sun L., Wang Y. et al.
Cell Reports Medicine, 2023Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses
Yuan S., Xu F., Li X. et al.
Olink Explore 3072/384
Science Translational Medicine, 2023A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19
Van Damme K., Hoste L., Declercq J. et al.
Journal for ImmunoTherapy of Cancer, 2023Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer
Anker J., Pal S., Kim-Schulze S. et al.
Liver International, 2023Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation‐related markers
Stankevic E., Israelsen M., Juel H. et al.
Journal of Endocrinological Investigation, 2023Serum biomarkers related to frailty predict negative outcomes in older adults with hip fracture
Cedeno-Veloz B., Lozano-Vicario L., Rodríguez-García A. et al.
Olink Target 48
Journal of Cancer Research and Clinical Oncology, 2023Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study
Pham T., Nimptsch K., Papadimitriou N. et al.
Antioxidants, 2023Genetics of Plasma Bilirubin and Associations between Bilirubin and Cardiometabolic Risk Profiles in Danish Children and Adolescents
Ullah A., Stankevic E., Holm L. et al.
Journal of Cerebral Blood Flow & Metabolism, 2023A cluster of blood-based protein biomarkers associated with decreased cerebral blood flow relates to future cardiovascular events in patients with cardiovascular disease
Overmars L., Kuipers S., van Es B. et al.
iScience, 2023Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19
Shivram H., Hackney J., Rosenberger C. et al.
Nature Immunology, 2023Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
Zhao J., Stacey D., Eriksson N. et al.
eClinicalMedicine, 2023Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study
Zinzani P., Trněný M., Ribrag V. et al.
Nature Genetics, 2023Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis
Zhou S., Sosina O., Bovijn J. et al.
Environmental Science & Technology, 2023Effects of Short- And Medium-Term Exposures to Lower Air Temperature on 71 Novel Biomarkers of Subclinical Inflammation: Results from the KORA F4 Study
Ni W., Breitner S., Nikolaou N. et al.
Allergy, 2023Dupilumab‐induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis
Ryser F., Yalamanoglu A., Valaperti A. et al.
Clinica Chimica Acta, 2023Identification of novel candidate biomarkers for acute myocardial infarction by the Olink proteomics platform
Liu J., Chen B., Lu H. et al.
2996 publications
Items per page
941-960 of 2996 publications